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Introduction: Silent ischemia is an asymptomatic form of myocardial ischemia, not associated 
with angina or anginal equivalent symptoms, which can be demonstrated by changes in ECG, 
left ventricular function, myocardial perfusion, and metabolism. The aim of this study was to 
evaluate the prevalence of silent myocardial ischemia in a group of patients with asymptomatic 
carotid stenosis.
Methods: A total of 37 patients with asymptomatic carotid plaques, without chest pain or 
dyspnea, was investigated. These patients were studied for age, sex, hypertension, diabetes, 
dyslipidemia, smoking, and family history of cardiac disease, and underwent technetium-99 m 
sestamibi myocardial stress-rest scintigraphy and echo-color Doppler examination of carotid 
arteries.
Results: A statistically significant relationship (P = 0.023) was shown between positive respond-
ers and negative responders to scintigraphy test when both were tested for degree of stenosis. 
This relationship is surprising in view of the small number of patients in our sample. Individuals 
who had a positive scintigraphy test had a mean stenosis degree of 35% ± 7% compared with a 
mean of 44% ± 13% for those with a negative test. Specificity of our detection was 81%, with 
positive and negative predictive values of 60% and 63%, respectively.
Conclusion: The present study confirms that carotid atherosclerosis is associated with coronary 
atherosclerosis and highlights the importance of screening for ischemic heart disease in patients 
with asymptomatic carotid plaques, considering eventually plaque morphology (symmetry, 
composition, eccentricity or concentricity of the plaque, etc) for patient stratification.
Keywords: asymptomatic carotid artery disease, silent myocardial ischemia, myocardial stress 
scintigraphy
Introduction
For many years angina pectoris has been considered the cardinal symptom of myocar-
dial ischemia. Nevertheless, studies beginning in the 1980s have shown that asymptom-
atic ischemia is the most common manifestation of coronary heart disease (CHD).1,2 
For example, many reports have documented that between 25% and 45% of patients 
with acute and chronic ischemic syndromes have evidence of myocardial ischemic 
episodes during daily activities, with minimal or no physical exercise,3,4 and greater 
than 75% of these are not associated with angina or anginal equivalent symptoms.4
Silent myocardial ischemia (SMI) is defined as the presence of objective findings 
suggestive of ischemia in the absence of chest pain or other anginal equivalent symp-
toms (dyspnea, arrhythmia).5Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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Table 1 Baseline demographic and clinical variables
No. patients N = 37
Age (years) 66 ± 8
Male sex (%) 25 (68)
Family history (%) 17 (46)
Hypertension (%) 19 (51)
Diabetes (%) 8 (22)
Dyslipidemia (%) 20 (54)
Smoking (%) 10 (27)
Stenosis (%) 0.4 ± 0.12
Exercise test
  Positive (%) 10 (27)
  Doubt (%) 3 (8)
  Negative (%) 24 (65)
ECG ST depression
  0 (%) 24 (65)
  0–1 (%) 3 (8)
  .1 (%) 10 (27)
  Perfusion defect 0.86 ± 1.06
Site of stenosis
  Bilateral internal carotid (%) 1 (3)
  Left common carotid (%) 1 (3)
  Right internal carotid (%) 8 (22)
  Right common carotid (%) 3 (8)
  Bilateral common carotid (%) 3 (8)
  Left internal carotid (%) 13 (35)
  Left carotid bifurcation (%) 3 (8)
  Right carotid bifurcation (%) 5 (14)
Degree of stenosis
  No stenosis (%) 0 (0)
  Mild stenosis (%) 16 (43)
  Moderate stenosis (%) 17 (46)
  High stenosis (%) 4 (11)
  Very high stenosis (%) 0 (0)
Note: Mean values ± SD or number and percentage of patients.
Objective evidence of myocardial ischemia may be:
•	 Exercise testing or ambulatory monitoring shows tran-
sient ST segment changes;
•	 Nuclear imaging studies demonstrate myocardial perfu-
sion defects;
•	 Reversible regional wall motion abnormalities are pro-
voked during stress or dobutamine echocardiography.
It has been estimated that in a population of male adults, 
the prevalence of SMI is 2% to 4%6 but the percentage is 
higher in patients affected by stable angina and in post-
infarction patients.7 Nevertheless, despite the fact that 
patients without clinical manifestations, but with positive 
results to the exercise test, have been reported to have a 27% 
higher incidence of acute coronary syndromes,8 the clinical 
relevance of SMI is still underestimated.
Although atherosclerosis is a pathological multifocal 
and multiregional process, a non-invasive evaluation by 
ultrasonography of unique regions like the carotid artery 
wall find great applicability in a more precise estimate of the 
overall progression of atherosclerosis and, consequentially, of 
cardiovascular risk profile. Based on the evident association 
between asymptomatic carotid stenosis and silent obstruc-
tive coronary artery disease,9–12 the aim of this study was to 
evaluate the prevalence of SMI in a group of patients with 
asymptomatic carotid artery plaques. The main methods uti-
lized in this observational study were high definition vascular 
echotomography and technetium-99m sestamibi myocardial 
stress-rest scintigraphy.
Methods
Study population
Thirty-seven patients (25 males) with asymptomatic 
carotid plaques and free from chest pain or dyspnea, aged 
66 ± 8 years, admitted to the Cardiology Unit, Emergency 
and Organ Transplant Department of Bari University General 
Hospital, were enrolled in the study.
All patients were carefully assessed for classic coronary 
risk factors: age, sex, essential hypertension, dyslipidemia, 
smoking, diabetes, a family history of cardiac disease 
(Table 1). Prior written informed consent was obtained to 
undertake technetium-99m sestamibi myocardial stress-rest 
scintigraphy and echo-color Doppler examination.
A hypertension state was defined as a systolic blood 
pressure of .140 mm Hg and/or diastolic blood pressure 
was .90 mm Hg. In addition, in accordance with the NCEP 
ATP III,13 all patients had hypercholesterolemia, defined as 
total cholesterol $220 mg/dL or the use of lipid-lowering 
drug(s).
Diabetes was defined as fasting blood sugar $126 mg/dL, 
blood sugar during 75 g oral glucose   tolerance test $200 mg/dL, 
or the use of antidiabetes drug(s).
Carotid ultrasound scanning
All patients underwent a two-dimensional echo-color 
Doppler examination of carotid arteries bilaterally using 
a high-definition vascular echograph (Philips SONOS 
5500 ultrasonographer, Bothell, WA) and a 7.5 MHz high-
resolution probe.
Patients were placed in supine position with their neck in 
extension and rolled contralaterally by about 45°. The carotid 
arteries were examined in the long- and short-axis view. Each 
scan was made by the same investigator.
The Mannheim carotid intima-media thickness consensus 
(2004–2006)14 defined evaluation criteria of intima-media 
thickness (IMT) and atherosclerotic plaques. The presence of 
atherosclerotic plaques can be diagnosed by detection of an Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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IMT . 1.3 mm or a focal structure emerging from the wall 
of at least 0.5 mm or 50% of the surrounding IMT value.
In our study the degree of carotid artery stenosis was 
graded as: 1) no stenosis; 2) mild: 1% to 39% stenosis; 
3) moderate: 40% to 59% stenosis; 4) high-grade: 60% to 
79% stenosis; 5) very high grade: 80% to 99% stenosis.
Myocardial stress-rest scintigraphy
Technetium-99m sestamibi myocardial perfusion stress-rest 
scintigraphy was performed in all patients.
The stress test was carried out on the bicycle ergometer 
e-Bike (GE Healthcare, West Milwaukee, WI), with patients 
in the sitting position, under continuous ECG monitoring 
(MAC5500, GE Healthcare, West Milwaukee, WI), pro-
gressively increasing the load by 25 W every 2 minutes, 
until exhaustion, symptoms, or .1 mm ST segment depres-
sion developed. The stress test was considered positive for 
myocardial ischemia when the ECG showed an ST segment 
depression .1 mm measured 80 msec after the J point.
All patients received an intravenous dose of technetium-
99m sestamibi at peak physical stress (peak heart rate .80% 
of the predicted value for age), 30 to 60 seconds before the 
end of exercise. After administration of the radiopharmaceu-
tical the patients were give milk to drink (light fatty meal) to 
eliminate the drug from the gallbladder through the gastro-
intestinal tract, and to minimize interference.
One hour after the drug injection the patients underwent 
SPECT (single photon emission computed tomography) to 
acquire stress images.
The next day, 1 hour after the injection of the same 
technetium-99m sestamibi quantity, they underwent the rest 
test, so that the interval between resting and exercise studies 
was .24 hours.
Images were acquired using a large-field, dual-headed, 
Infinia gamma camera (GE Healthcare), equipped with a 
high resolution collimator. A semicircular orbit of 180°, 
from 45° right anterior oblique to 45° left posterior oblique, 
and with step detections every 3°, was carried out. Image 
reconstruction, display, and analysis were performed by 
standard software package using Xeleris Workstation (GE 
Healthcare). Filtered back projection was performed with a 
low-resolution Butterworth filter with a cut-off frequency of 
0.5 cycles/pixel, order 5.0. No attenuation or scatter correc-
tion was applied. The left ventricle transaxial tomographic 
slices were reoriented into the short, horizontal, and vertical 
long-axis views according to current recommendations.
The following myocardial regions were evaluated: 
anterior, apical, septal, inferior, and lateral. The uptake in 
each of these regions was evaluated as normal, equivocal, 
mild defect, moderate defect, or severe defect (similar to the 
background uptake).
Analysis of the results revealed areas of myocardial infarc-
tion (MI) (a perfusion defect at rest and stress test) and myo-
cardial ischemia (a perfusion defect only at the stress test).
Statistical analyses
Continuous variables were expressed as mean values ± 
standard deviation, and frequencies as the number and per-
centage of patients. Categorical variables were compared 
between groups using the chi-squared or Fisher’s exact test 
as appropriate. The other between-group comparisons were 
made by means of non-parametric Mann–Whitney U test. 
P values of ,0.05 were considered statistically significant. 
The data were analyzed using the statistical software package 
Statistica version 6.1 (StatSoft Inc., Tulsa, OK).
Results
Table 1 gives the baseline demographic and clinical vari-
ables of the studied population, showing that all patients 
had a certain (40% ± 12%) degree of carotid stenosis (within 
mild, moderate, and high, according to our classification of 
plaques in the Methods section) although the exercise test 
was positive in at least 10 individuals (27%).
Table 2 shows the results of scintigraphy, related to 
the degree of stenosis detected by echo-color Doppler. 
We   compared scintigraphy data even against common car-
diovascular risk factors. A statistically significant relation-
ship (P = 0.023) was shown between positive responders 
and negative responders to scintigraphy test when both were 
tested for degree of stenosis. This relationship is surpris-
ing in view of the small number of patients in our sample. 
  Individuals who had a positive scintigraphy test had a mean 
stenosis degree of 35% ± 7% compared with a mean of 
44% ± 13% for those with a negative test.
Table 2 Baseline demographic and clinical variables by scintigraphy
No. patients Positive  
n = 16
Negative  
n = 21
P value
Age (years) 66 ± 8 66 ± 8 0.51
Male sex (%) 14 (88) 11 (52) 0.024
Family history (%) 6 (38) 11 (52) 0.37
Hypertension (%) 10 (63) 9 (43) 0.24
Diabetes (%) 1 (6) 7 (33) 0.10
Dyslipidemia (%) 8 (50) 12 (57) 0.67
Smoking (%) 4 (25) 6 (29) 1.00
Stenosis 0.35 ± 0.07 0.44 ± 0.13 0.023
Note: Mean values ± SD or number and percentage of patients.Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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Table 3a and 3b is a simple expression of the importance 
of scintigraphy test in our studied population. In particular we 
noticed that: 10 patients (27%) had a negative ECG but positive 
scintigraphy, 17 (46%) had both a negative ECG and scintigra-
phy, 4 patients (11%) had a positive ECG but negative scintig-
raphy, and 6 (16%) had a positive ECG and scintigraphy.
These results are very important because they emphasize 
some of the statistical parameters that are useful in helping to 
understand the real importance of our instrumental tools. We 
can notice that we have reached a good degree of specificity 
of the test (81%) with a positive and negative predictive value 
of 60% and 63%, respectively.
In the end, we can underline that the results showed an 
important association between significant carotid stenosis 
and a positive stress test.
Table 4 shows that, among the 16 patients with   positive 
scintigraphy findings, all had at least 1 risk factor: 8 patients 
(50%) had 1 risk factor, 4 ( 25%) had 2 risk   factors, 
3 (18.75%) had 3 risk factors, and 1 (6.25%) had 4 risk 
  factors. Among the 21 patients with negative scintigraphy: 
1 patient ( 4.76%) had no risk factors, 3 (14.29%) had 1 risk 
factor, 10 (47.62%) had 2 risk factors, 6 (28.75%) had 3 risk 
factors, and 1 ( 4.76%) had 4 risk factors.
Discussion
SMI is a documented ischemia in the absence of chest dis-
comfort or other anginal equivalents. It is the most common 
manifestation of CHD.5
About 40% of patients with CHD have acute episodes of 
myocardial ischemia during daily life; 75% of these episodes 
are asymptomatic and considered silent (SMI).15 Conscious-
ness of the incidence of SMI in high-risk populations can 
reduce cardiovascular events and death rates.
In the Framingham Study, about 24% of the patients who 
suffered from heart attack had unrecognized episodes.16 Half 
of these episodes were silent, and the other half were atypical 
(events accompanied by some symptoms that neither physician 
nor patient recognize as manifestations of a heart attack).
The precise mechanism for pathogenesis and pathophysi-
ology of SMI remains to be clarified. Beta-adrenergic 
receptors, adenylyl cyclase, and guanine nucleotide binding 
proteins (G proteins) are considered to have an important 
role in the myocardial ischemic process of SMI.17
SMI happens when myocardial ischemia causes ECG 
changes but fails to reach the pain threshold, or when isch-
emia is less severe and of shorter duration than symptomatic 
ischemia.18 Some patients may not perceive chest pain during 
myocardial ischemia because they have a high pain thresh-
old, or possibly because they have a defective perception of 
painful stimuli.19,20 In diabetes patients, it is suspected that 
partial or complete autonomic denervation may contribute 
to the prevalence of silent ischemia.21,22
SMI is associated with a circadian pattern, and many events 
occur in the morning. This may be because of elevated heart 
rate and blood pressure, higher catecholamine concentrations, 
increased coronary vasomotor tone, greater platelet aggrega-
tion response, and a reduced intrinsic fibrinolytic process.
Diabetes, hypertension, previous MI, surgical revascu-
larization, and advanced age are all presumed risk factors 
for silent ischemia,23 even though many affected individuals 
do not have any apparent risk factors and seem to be totally 
asymptomatic.
The detection of patients affected by SMI is an ambi-
tious project but difficult to perform in a general population. 
It could be useful in patients with epi-aortic stenotic vessel 
lesions, in whom there is a high prevalence of coronary dis-
ease. Schoenenberger et al24 tried to solve the problem in their 
study. They considered 54 patients with SMI out of the Swiss 
Interventional Study on Silent Ischemia Type I (SWISSI I) 
study.25 In this case SMI was assessed by bicycle ergometry 
Table 3a Correlations between simple scintigraphy and exer-
cise test
Exercise test Scintigraphy Total
Negative Positive
Negative 17 10 27
Positive 4 6 10
Totals 21 16 37
Table 3b Evaluation of scintigraphy test in our population
Estimated value (95% 
confidence interval)
Prevalence (%) 43 (28–60)
Sensitivity (%) 38 (16–64)
Specificity (%) 81 (57–94)
Positive predictive value (%) 60 (27–86)
Negative predictive value (%) 63 (42–80)
Table 4 Population risk factors and scintigraphy results
Risk factors (no.) Scintigraphy
Negative Positive
0 (%) 1 (4.76) 0 (0)
1 (%) 3 (14.29) 8 (50)
2 (%) 10 (47.62) 4 (25)
3 (%) 6 (28.75) 3 (18.75)
4 (%) 1 (4.76) 1 (6.25)
Totals 21 (56.75) 16 (43.25)Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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and stress imaging (echocardiography or   scintigraphy). 
In this way they found a high incidence of relevant CAD 
among totally asymptomatic patients with myocardial isch-
emia during stress testing. They reported that previously 
healthy subjects with exercise-induced ST-segment depres-
sion at check-up examinations, even if asymptomatic, should 
have further diagnostic evaluation. Similar findings come 
from Schoenenberger et al,26 who evaluated the occurrence of 
sudden cardiac death (SCD) in patients with silent ischemia 
after MI coming from the SWISSI II. Patients (201) with 
silent ischemia after MI were randomized to percutaneous 
coronary intervention (PCI) or medical management. The 
main end point of their analysis was SCD. Patients with 
silent ischemia after MI undergoing PCI had better long-
term left ventricular ejection fraction and a reduced SCD 
incidence. But a PCI procedure in patients with SMI seems 
unnecessarily aggressive. Nuclear imaging seems to be the 
answer to this problem. Zellweger et al,27 who analyzed 3664 
asymptomatic patients “without” CAD history undergoing 
SPECT, observed that $7.5% ischemic myocardium was 
related to high risk factors. Scholte et al28 had earlier reported 
the importance of imaging nuclear techniques in evaluation 
of SMI in individuals with type 2 diabetes. Several studies 
have shown that SMI is predictive of increased cardiac risk 
in diabetic and elderly patients.19,29,30
The results of our study seem to be an intellectual para-
dox: scintigraphy seems to be positive in patients with SMI 
and a low degree of carotid IMT (35% ± 7%), and negative 
in patients with SMI and moderate degree of carotid IMT 
(44% ± 13%) (significant, P = 0.023). This result could be 
due to the small sample analyzed or, more likely, other condi-
tions that could not be identified by nuclear imaging could 
have influenced the results. In particular we speculate about 
carotid plaque characteristics such as its morphology and 
inner constitutions. These peculiarities could be related to 
ischemic disorders. In fact, a small plaque, perhaps eccentric 
or in a condition of inner inflammation, could be considered 
even worse than a larger one calcified or stable.31,32 It could be 
possible that a younger peripheral plaque, not well established 
in the arterial wall and not overcome by the development of 
collateral series of vessels, could become more dangerous 
than a well-established one. This latest one, named “stable 
plaque” cause of a calcification process and unable to induce 
a really hemodynamical impairment thanking the collateral 
pathways, would go to a rupture process less frequently than 
a younger one. For this reason patients with stable plaques 
would have a number of positive stress tests inferior than the 
ones with younger plaques. However, more studies on such 
an argument are needed in the near future in order to clarify 
our data and the values coming from our research.
In clinical practice it is difficult to identify subjects with 
a high risk of SMI among an asymptomatic population. 
The rationale for identifying patients with SMI is that this 
disorder is associated with an increase in coronary risk.
All patients with carotid plaques and cerebrovas-
cular disease who are eligible for the exercise stress 
test should undergo stress test screening for the risk 
of heart attack. Patients who are not candidates for the 
stress test may undergo dipyridamole scintigraphy or 
echocardiography.33
Our results showed that the prevalence of SMI in a popu-
lation affected by silent obstructive carotid artery disease was 
high, no less than 43%. Other published studies have reported 
an SMI prevalence ranging from 23% to 40%.34,35 These 
differences are likely due to the different techniques used 
and the variability of the studied population. A specificity 
of 81% was reached in our population but the small sample 
could influence such a result.
The high prevalence of SMI in our selected population 
with suspected coronary disease further stresses the impor-
tance of this screening, both for improving quality of life 
and extending survival.
Study limitations
The small sample we evaluated could represent a limita-
tion of our study. Nevertheless, our findings could help 
to improve our understanding of the relationship between 
heart and peripheral artery function in myocardial ischemia. 
Further investigation is needed in order to improve research 
in this field.
Conclusion
This study suggests a correlation between carotid and coro-
nary atherosclerosis, but the result of most interest is the 
apparent paradoxical finding of a positive scintigraphy test 
with a lower degree of stenosis. This result highlights the 
need for further analysis in order to determine the importance 
of plaque morphology in cardiovascular risk stratification of 
a patient with SMI.
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